Walleye Capital LLC Legend Biotech Corp Transaction History
Walleye Capital LLC
- $46.2 Billion
- Q3 2024
A detailed history of Walleye Capital LLC transactions in Legend Biotech Corp stock. As of the latest transaction made, Walleye Capital LLC holds 2,993 shares of LEGN stock, worth $97,242. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,993
Previous 76,800
96.1%
Holding current value
$97,242
Previous $3.4 Million
95.74%
% of portfolio
0.0%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding LEGN
# of Institutions
225Shares Held
74.3MCall Options Held
279KPut Options Held
350K-
Price T Rowe Associates Inc Baltimore, MD11.2MShares$363 Million0.06% of portfolio
-
Ra Capital Management, L.P. Boston, MA7.51MShares$244 Million5.1% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E96.64MShares$216 Million7.41% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$186 Million0.01% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.04MShares$164 Million1.16% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $5.44B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...